GT Biopharma Applies to List on NASDAQ Capital Market Listing

GT Biopharma (OTCQB:GTBP) announced it filed an application to list their stock on the NASDAQ Capital Market.
As quoted in the press release:

GT Biopharma is currently quoted as GTBP: OTCQB on the Over the Counter Market.
“We believe that elevating the listing of our common stock to the NASDAQ Capital Market is an important step forward in our mission to enhancing shareholder value. The NASDAQ listing should enable us to enhance trading liquidity of our stock, provide greater access to capital markets, broaden our shareholder base, and raise our profile in the investment community,” said Anthony Cataldo, Executive Chairman.

Click here to read the full press release.

Source: www.accesswire.com